This knowledge, in combination with our finding that miR-766 is elevated in p53-mutant cancers (Supplementary Figure 1) complicates the association between miR-766 and malignancy identified in the earlier studies of lung adenocarcinoma [32] and cutaneous squamous cell carcinoma [31]. This evidence concerns the gene TP53 and cutaneous squamous cell carcinoma.